Is COVID-19 Friend or Foe to Industry 4.0: Experiences of Turkish White Goods Suppliers

被引:0
|
作者
Demirbag, Kubra Simsek [1 ]
Yildirim, Nihan [2 ]
机构
[1] Gumushane Univ, Management Informat Syst Dept, Gumushane, Turkey
[2] Istanbul Tech Univ, Management Engn Dept, Istanbul, Turkey
关键词
covid-19; fourth industrial revolution; industry; 4.0; pandemic; white goods;
D O I
10.1109/TEMSCONEUROPE54743.2022.9801958
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
This study, in the two years since the beginning of the COVID-19 pandemic, reveals the most focused issues by the Turkish white goods suppliers regarding Industry 4.0 and the challenges encountered while engaging in Industry 4.0 practices. The data were obtained through a questionnaire form participated by the managers of 36 different companies that are members of the Turkish White Goods Suppliers Association. The collected data were classified, and it was found that the most focused issues of the companies were technology investments, ERP and MES, data collection, business processes, investment plans, organizational transformation, occupational health and safety, and participation in Industry 4.0-related events, respectively. Moreover, the most common challenges companies face concerning Industry 4.0 are related to the not being able to come together, finance, technology providers, postponement of investment plans, and loss of employees. On the other hand, 16% of the participating companies stated that they did not encounter any difficulties.
引用
收藏
页码:67 / 72
页数:6
相关论文
共 50 条
  • [1] NSAIDs in COVID-19, friend or foe?
    Abaalkhayl, Mohammed Soliman
    ANAESTHESIA PAIN & INTENSIVE CARE, 2022, 26 (04) : 554 - 558
  • [2] Testosterone in COVID-19: Friend or Foe?
    Peter J. Niemann
    Heidi V. Goldstein
    Endocrine, 2021, 71 : 281 - 282
  • [3] Estrogen and COVID-19: friend or foe?
    Di Vincenzo, A.
    Andrisani, A.
    Vettor, R.
    Rossato, M.
    ANNALS OF ONCOLOGY, 2021, 32 (07) : 934 - 934
  • [4] The COVID-19 facemask: Friend or foe?
    Hallock, Geoffrey G.
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2021, 74 (05): : 1149 - 1150
  • [5] NSAIDs in COVID-19, friend or foe?
    Mahrous, Reham
    Abdelnasser, Amr
    Fouda, Raghda
    Morsy, Mohamed Abd Al Moniem
    Mandour, Omnia
    ANAESTHESIA PAIN & INTENSIVE CARE, 2023, 27 (01) : 119 - 122
  • [6] Testosterone in COVID-19: Friend or Foe?
    Niemann, Peter J.
    Goldstein, Heidi V.
    ENDOCRINE, 2021, 71 (02) : 281 - 282
  • [7] COVID-19 and diabetes: Is metformin a friend or foe?
    Ursini, Francesco
    Ciaffi, Jacopo
    Landini, Maria Paola
    Meliconi, Riccardo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 164
  • [8] The complement system in COVID-19: friend and foe?
    Java, Anuja
    Apicelli, Anthony J.
    Liszewski, M. Kathryn
    Coler-Reilly, Ariella
    Atkinson, John P.
    Kim, Alfred H. J.
    Kulkarni, Hrishikesh S.
    JCI INSIGHT, 2020, 5 (15)
  • [9] Oxygen: Friend or foe in the COVID-19 battle
    Chudasama, Kishan
    Sangey, Esmail
    CLINICAL CASE REPORTS, 2021, 9 (12):
  • [10] Azithromycin in patients with COVID-19: Friend or foe?
    Kow, Chia Siang
    Hasan, Syed Shahzad
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (01) : 136 - 137